Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds. On November 1, TD Cowen analyst Brendan Smith touted the progress the company has made ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

One person that helped bring the chill was an analyst cutting his price target. Another two were executives at the biotech selling chunks of stock. The company was the target of an analyst price ...

We may receive commissions from some links to products on this page. Promotions are subject to availability and retailer terms. But like most financial tools, there are also complexities and potential ...

We may receive commissions from some links to products on this page. Promotions are subject to availability and retailer terms. This timing couldn't be better, either, as this year has ushered in ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

New research has identified the mechanism by which air pollution damages the lungs’ self-cleaning system, leaving us vulnerable to infection. In doing so, it has also identified a way to reverse that ...

Python’s new template strings, or t-strings, give you a much more powerful way to format data than the old-fashioned f-strings. The familiar formatted string, or f-string, feature in Python provides a ...

The primary results of the REVERSE-IT trial showed that bentracimab restored platelet function, demonstrating the ability to reverse the effects of ticagrelor in patients on ticagrelor who underwent ...